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Hysterectomy is the most frequently performed major gynecologic surgical procedure 
(Altgassen et al. 2004; Briese V. et al. 2002). The overall rate of hysterectomy in Germany in 
2005 - 2006 was 362.9 (295.0 for benign diseases of the genital tract and 44.0 for primary 
malignant tumors of the genital tract) per 100,000 person-year. Hysterectomy rates varied 
considerably across federal states: the rate for benign disease was lowest in Hamburg (213.8 
per 100 000 women per year) and highest in Mecklenburg–West Pomerania (361.9 per 100 
000 women per year) (Stang et al. 2012). The CDC (Centre for Disease Control and 
Prevention) reported that in USA, the rate of the hysterectomy operation in 2000 - 2004 was 
5.4/ 1000 per year (Whiteman et al. 2008). The art of surgery has developed and changed with 
the advancement of technology so that hysterectomy nowadays is mostly a minimal invasive 
operation. 
The history of hysterectomy started in England with Charles Clay, passing over to Ellis 
Burnham who performed the first successful abdominal hysterectomy (Graham 1951; Benrubi 
1988). The development of hysterectomy in the German speaking countries is to be granted to 
the following names; Osiander (1759–1822), Sauter (1776–1840), Freund (1833–1917) and 
Czerny (1872–1916) (Zubke W. et al. 2006; Zubke W. et al. 2006; Zubke W. et al. 2006). The 
Development of anesthesia and antibiotics led the way to the establishment of VH and AH as 
the standard operation routes for hysterectomy. In 1988 Harry Reich succeeded in performing 
the first laparoscopic hysterectomy (Reich 1992) followed by Kurt Semm with the first CISH 
(Classic Intrafascial Supracervical Hysterectomy) (Semm K. 1991) and then Donnez in 1993 
with the traditional laparoscopic hysterectomy which is still performed today (Donnez, J. et 
al. 1993). The evolvement and development of the advantages of the laparoscopic technique 
resulted in decreasing the AH by 6-7% annually (Brandner et al. 1995; Neis K.J. et al. 1993).  
Benign indications of hysterectomy are symptomatic or growing uterine myomas, 
adenomyosis uterus, dysfunctional uterine bleeding, endometriosis and prolapse of the uterus 
(Hornemann A. et al. 2008; Kaufmann M. et al. 2006). Uterine myomas are the most common 
indication of hysterectomy (Müller A. et al. 2004), myomas cause three main symptoms: pain, 
bleeding symptoms and infertility (Müller A. et al. 2004; Müller A. et al. 2007). In 2010 the 
indications for hysterectomy in Germany according to the AQUA- Institute were myomas 
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60.5%, prolapse 26.7%, menstrual disorders 25.8%, hyperplasia of the uterus and cervix 2.0% 
and endometriosis 12.9%. 
Three hysterectomy approaches can be distinguished: abdominal, vaginal, and laparoscopic. 
Traditionally, abdominal hysterectomy was used with gynecological malignancy or if the 
uterus was enlarged. It remains the ‘fallback option’ if the uterus cannot be removed by 
another approach. Vaginal hysterectomy was originally used for prolapse and dysfunctional 
uterine bleeding when the uterus was of fairly normal size (Johnson et al. 2006). The LH was 
known as an alternative to abdominal hysterectomy, however in the 1990s, most 
gynecologists ‘adopted’ the alternative laparoscopic-assisted vaginal hysterectomy (LAVH), 
an operation requiring more technical skills than the vaginal or abdominal method (Reich 
2007). The choice of the hysterectomy route is dependent on many factors; the size and 
mobility of the uterus, the BMI, preoperative history and anatomical variation, level of 
experience of the surgeon and the patient’s wish (Johnson et al. 2006). 
Socioeconomic factors hinder the indications for vaginal hysterectomy as later first deliveries, 
fewer vaginal deliveries and more caesarean operations are all obstacles for vaginal delivery 
and put more pressure on the surgeons to achieve a safe laparoscopic surgery. These factors 
amplify the crucial need for better training programs for laparoscopic surgery.  
The ACOG agreed with the AGE that VH is the method of choice of all hysterectomy routes 
for benign indications (2009; Reich et al. 1999). VH has the shortest operation duration, 
shortest hospital stay, a lower complication rate and fastest postoperative reconvalescence 
(Schindlbeck et al. 2008). On the other hand, a large uterus, a narrow vaginal space, a planned 
adnectomy and endometriosis excisions are limiting factors for a the VH (Hornemann A. et al. 
2008; Schindlbeck et al. 2008). The laparoscopic hysterectomy is the method of choice 
whenever a VH is not possible (Muller et al. 2010; Kovac et al. 2002). The least blood loss, 
the shortest hospital stay and better cosmetic results are the well-known advantages of 
laparoscopic hysterectomy (Müller A. et al. 2005; Schindlbeck et al. 2008).  
A well-trained operative team is necessary to achieve a safe surgery with a lower 
complication rate and a shorter operation time (Schindlbeck et al. 2008; Lyons 2000). In 
2010, the VH represented 59.9 % and AH 19.3 % in Germany ; while in the USA VH 
represented 22%, AH 64% and LAVH 14% (Jacobson et al. 2009). More complications 
occurred after abdominal compared to vaginal and laparoscopic hysterectomies. The amount 
of blood loss depended on the type of hysterectomy. More blood loss and a slower 
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convalescence were recorded during abdominal hysterectomy, so that the trend worldwide is 
to limit the incidence of AH (2009; Aniuliene et al. 2007; David-Montefiore et al. 2007). 
Non-operative treatment or alternatives to hysterectomy are a preferred option for many 
patients seeking a uterus-preserving therapy such as myoma enucleation or medical treatment. 
Hysteroscopic myoma removal is to be advised for submucus myoma with 50% invasion of 
the uterus cavity (ESGE Typ 0 and I). GNRH analogues are recommended for myomas > 3cm 
to decrease the circumference of the myoma (Al-Mahrizi et al. 2007; Mukhopadhaya et al. 
2008); however, the risk of perforation and reoperation must be considered. Ipristal acetate is 
a first-in-class, orally active, selective progesterone receptor modulator. It reversibly blocks 
the progesterone receptors in target tissues. As recently published in the New England Journal 
of Medicine, the 12 week once-a-day oral therapy (vs. injectable GnRH agonist) is effective 
in stopping uterine bleeding, correcting anaemia and shrinking myoma volume. It improves 
the quality of life and has no castration side effects, unlike GnRH agonists. There are no data 
available on treatment duration longer than 3 months. The localization and size of the myoma 
are the main determining factors for the decision to undertake a laparoscopic myoma 
enucleation. The less blood loss, less postoperative pain and faster reconvelescence are the 
main advantages of that technique (Palomba et al. 2007). Uterine artery emobilization is an 
alternative to operative treatment (Bradley 2009; Fennessy et al. 2011). The Cochrane review 
showed an advantage of a short hospital stay and a shorter convalescence period (Gupta et al. 
2012). Medical treatment with long usage of contraceptives could also be advised as a 
treatment alternative; oral contraceptives can lead to a reduction in bleeding symptoms of up 
to 40% (2010). 
The aim of this study is to investigate the different operative routes and methods of 
hysterectomy. Different factors seem to influence the decision for the desired hysterectomy 
procedure.   
This study has the following specific aims: 
- To outline the indications for the hysterectomy operations 
- To outline the development of the hysterectomy procedures 
- To compare the different complication rates and outcomes and their association with 
the operation route 
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2. Material and Methods 
2.1 Patients 
Between January 2002 and October 2010 954 patients underwent hysterectomy at the 
Department of Gynecology and Obstetrics, University Hospitals, Campus Kiel Schleswig-
Holstein, for the indication of a benign disease. Indications varied from fibroids (with 
symptomatic complains and growing fibroid) to dysfunctional uterine bleeding, adenomyotic 
formations, endometriosis and precancerous lesions of the uterus or the cervix. The relevant 
criteria of this group of patients were collected and analyzed including the operation 
indications, operation duration, length of hospital stay, body mass index, weight of the 
extracted uterus, histopathological results from the excised specimen, PAP results, 
complications (intra and post- operative) and the hemoglobin fall after the operation. 
All patients with malignant histopathological results were excluded from the study. The 
precancerous lesion of the cervix was identified by the Papanicolaou test (also called Pap 
smear), which is a screening test used to detect potentially pre-cancerous and cancerous 
processes in the endocervical canal (transformation zone) of the female reproductive system.  
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2.2. Operative techniques 
2.2.1. Vaginal Hysterectomy (VH) 
1. Setting of the patient 
After appropriate general anesthesia the patient is placed in the dorsal lithotomy position with 
the buttocks well off the end of the table. The vulva and vagina are fully prepped with a 
surgical soap solution. A thorough bimanual examination is necessary prior to performing a 
hysterectomy. Placing a weighted posterior vaginal retractor into the vagina exposes the 
cervix. A small right-angle retractor is used to elevate the anterior vaginal wall; a second 
right-angle retractor displaces one lateral vaginal wall and exposes the cervix. Two Jacobs 
tenacula are used to grasp the anterior and posterior lips of the cervix and pull them into the 
vaginal introitus. 
2. Injection of vasoconstricting agent 
This solution should not be used on patients with hypertension or cardiac arrhythmias but is 
most useful in healthy premenopausal patients, as it reduces bleeding during dissection. 
After the injection of Pitressin into the vaginal mucosa the mucosa is incised with an 
electrical scalpel around the entire cervix. 
3. Bladder dissection 
While downward traction is applied on the Jacobs tenacula, the handle of the knife is used to 
dissect the bladder off the anterior lower uterine segment. A right-angle retractor is placed 
under the vaginal mucosa and bladder. Strong downward traction is applied to the Jacobs 
tenacula on the cervix and the peritoneal vesicouterine fold is grasped with pickup forceps 
and incised with sharp curved Cooper scissors. By elevating the peritoneal vesicouterine fold 
with the pickup forceps, a definite hole can be seen. 
4. Exposure of Cul-de-sac 
The Jacobs tenacula are brought acutely up toward the pubic symphysis, exposing the cul-de-
sac. Pickup forceps are used to retract the posterior vaginal cuff, thereby placing the 
peritoneum of the cul-de-sac on tension. The peritoneum of the cul-de-sac is incised with 
curved Cooper scissors.  
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5. Securing the uterosacral ligament 
The weighted posterior vaginal retractor is removed. With the two Heaney retractors the 
broad ligament is exposed from the uetrosacral ligament to the tubo-ovarian round ligament. 
With the cervix on upward and lateral retraction via the Jacobs tenacula, a curved Heaney 
clamp is placed in the posterior cul-de-sac with one blade underneath the uterosacral ligament 
and the opposite blade over the uterosacral ligament. The clamp is placed immediately next to 
the uterine cervix so that some tissue of the cervix is included in this clamp. 
6. Securing the cardinal ligament 
With the uterus on upward and lateral retraction via the Jacobs tenacula on the cervix, the 
cardinal ligament is clamped adjacent to the lower uterine segment and incised. The cardinal 
ligament is suture-ligated with 0 synthetic absorbable suture. 
7.  Securing the broad ligament 
When the uterosacral and cardinal ligaments on each side have been clamped, incised and 
suture-ligated, the remaining portion of the broad ligament attached to the lower uterine 
segment containing the uterine artery is clamped adjacent to the cervix. 
8. Delivery of the uterus 
With the uterosacral ligament, the cardinal ligament and the uterine artery pedicle on both 
sides now clamped, incised and suture-ligated, the cervix is retracted upward in the midline 
via the Jacobs tenacula. Thyroid clamps are used to grasp the posterior uterine wall and the 
fundus is delivered posteriorly. 
9. Ligation of round ligament 
Two Heaney clamps are applied to the tubo-ovarian round ligament and it is incised close to 
the fundus. The tubo-ovarian round ligament is tied twice. A tie of 0 synthetic absorbable 
sutures is placed behind the second clamp. The tubo-ovarian round ligament is tied with a 
simple 0 synthetic absorbable suture. After the clamp at the rear of the pedicle is removed, the 
forward clamp is "flashed" (i.e. slightly opened and immediately closed), to allow the suture 
to securely ligate all the structures in this pedicle. A second suture ligature is tied in a fixation 
stitch, placing the suture in the midportion of its pedicle. The suture is tied in front of and 
behind the pedicle prior to removing the first clamp. The pedicle is tied and the second suture 
is held in a straight clamp for traction. 
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10. Vaginal Closure 
The final step is to observe the upper vaginal area for hemorrhage. We prefer to catheterize 
the bladder at the end rather than at the beginning of the procedure. 
2.2.2 Abdominal Hysterectomy (AH) 
1. Patient setting 
The patient is placed in the dorsal lithotomy position and thorough pelvic examination is 
performed with the patient under general anesthesia. It is recommended to administer a Single 
dose of prophylactic antibiotics at the beginning of the operation. The patient is then put in 
approximately a 15° Trendelenburg position. A Foley catheter is left in the bladder and 
connected to straight drainage. For benign diseases the Pfannenstiel incision is an adequate 
alternative to the midline incision. After the abdomen is entered, it should be thoroughly 
explored; including the liver, gallbladder, stomach, kidneys and aortic lymph nodes. 
2. Opening of abdomen 
Self-retaining retractors are placed in the abdominal incision and the bowel is packed off with 
warm, moist gauze packs. A 0 synthetic absorbable suture is placed in the fundus of the uterus 
and used for uterine traction with two long clamps. The uterus is deviated to the patient's 
right. The left round ligament is placed on stretch and incised between clamps. 
3. Securing of round ligament 
The distal stump of the round ligament is ligated with 0 synthetic absorbable sutures. The 
proximal stump is held with a straight clamp. At this point the leaves of the broad ligament 
are opened both anteriorly and posteriorly.  
4. Opening of leaflets of broad ligament 
While retracting the uterus cephalad, the surgeon opens the anterior lead of the broad ligament 
to the vesicouterine fold. Steps 2-4 are carried out on the opposite side. 
5. Bladder dissection 
The vesicoperitoneal fold is elevated and the fine filmy attachments of the bladder to the 
pubovesical cervical fascia are visible. The bladder can be dissected off the lower uterine 
segment of the uterus and cervix by either blunt or sharp dissection.  
6. Ligation and securing of broad and suspensory ligament 
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If the ovaries are to be preserved, the uterus is retracted toward the pubic symphysis and 
deviated to one side with the infundibulopelvic ligament, tube, and ovary on tension. A finger 
should be inserted through the peritoneum of the posterior leaf of the broad ligament under 
the suspensory ligament of the ovary and fallopian tube. The tube and suspensory ligament 
are doubly clamped, incised and tied with 0 synthetic absorbable suture. The distal stump of 
this structure is best doubly tied, first with a single tie of 0 synthetic absorbable suture and 
then with a ligature of 0 synthetic absorbable suture. The same procedure is carried out on the 
opposite side. 
7. Ligation and securing of uterine artery pedicle 
The uterus is then retracted cephalad and deviated to one side of the pelvis with the lower 
broad ligament on stretch. Three curved clamps are placed at the junction of the lower uterine 
segment on the uterine vessels. An incision is made between the upper Ochsner clamp and the 
two lower Ochsner clamps. This is suture-ligated with two 0 synthetic absorbable sutures, 
placing the first suture at the tip of the lower Ochsner clamp and tying the suture behind the 
base of the clamp. The middle Ochsner clamp is left in place and is similarly suture-ligated by 
a second ligature placed at the tip of the Ochsner clamp and tied behind the base of the clamp. 
The same procedure is carried out on the opposite side. 
A delicate, transverse, curved incision is made in the pubovesical cervical fascia overlying the 
lower uterine segment.  
8. Mobilization of uterus 
The uterus is held in traction in the cephalad position and the handle of the knife is used to 
dissect the pubovesical cervical fascia inferiorly.  This step mobilizes the ureter laterally and 
caudally. 
9. Ligation and securing of cardinal ligament 
Two straight clamps are applied to the cardinal ligament within a distance of approximately 2 
cm. The cardinal ligament is incised between the two clamps and the distal stump is ligated 
with 0 synthetic absorbable sutures. The suture is tied at the base of the clamp. The same 
procedure is carried out on the opposite cardinal ligament. 
The posterior leaf of the broad ligament is incised down to the uterosacral ligaments and 
across the posterior lower uterine segment between the rectum and cervix. 
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10. Ligation and securing of uterosacral ligament 
The uterosacral ligaments on both sides are clamped between straight Ochsner clamps, 
incised and ligated with 0 synthetic absorbable sutures. 
11. Opening of vaginal vault 
The uterus is placed on traction cephalad, and the lower uterine segment. The vagina is 
entered by a stab wound with a scalpel and is cut across with either a scalpel or scissors. The 
uterus is removed. 
12. Closure of vaginal vault 
The edges of the vaginal mucosa are sutured with a running locking 0 synthetic absorbable 
suture starting at the edges of the vagina underneath the bladder and carried around to the 
stumps of the cardinal and uterosacral ligaments, which are sutured closing the vagina. 
13. Closure of the abdominal wall 
At this point the pelvis is thoroughly washed with sterile saline solution. Meticulous care is 
taken to ensure that hemostasis is present throughout the dissected area. 
The pelvis is reperitonealized with running 2-0 synthetic absorbable sutures from the anterior 
to the posterior leaf of the broad ligament. 
The choice of leaving drainage for 2 or 3 days after the operation is usually decided by the 
surgeon at the end of the operation.  
2.2.3 Total Laparoscopic Hysterectomy (TLH) 
1. Patient setting 
After the induction of anesthesia, the patient’s legs are placed in padded Allen stirrups. The 
buttocks must protrude a few centimeters from the edge of the table to allow uterine 
manipulation. It is recommended to administer a single dose of prophylactic antibiotics at the 
beginning of the operation. The abdomen, perineum and vagina are prepared with a suitable 
bactericidal solution and a Foley catheter is inserted.  
2. Insertion of uterine manipulator  
The Hohl uterine manipulator (Fa. Karl Storz, Tuttlingen, Germany) is inserted. Five safety 
measures are performed before insertion of the Veress needle; the aorta palpation test, the 
needle Flow test, the snap test, the hiss phenomenon and the aspiration test. The primary 
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trocar (umbilicus for camera entry) and the secondary trocar (right and left iliac fossa) are 
placed under vision to allow the exploration of the abdominal and pelvic anatomy. 
3. Separation of adnexa 
Stepwise, without bilateral salpingo-oophorectomy (BSO): The 2nd assistant retracts the 
uterus to the right without any anteflexion and with the utmost traction. Coagulation of the 
round, ovarian ligaments and the tube. 
4. Dissection of broad ligament and uterine artery  
With BSO, coagulate and cut the infundiblar pelvic ligament to remove the ovaries. This is 
followed by separation of the broad ligament by stepwise coagulation from the uterus and 
then coagulation and cutting of the uterine arteries with visualization of the ureter.  
5. Dissection of the bladder peritoneum 
The vesicouterine space is opened. At the vesico-uterine junction coagulate lightly and retract 
the bladder down and away from uterus. Urinary bladder dissection is not necessary using the 
Hohl manipulator. 
6. Excision of the uterus 
The surgeon coagulates and cuts laterally to the cervix to release the sacrouterine ligaments. 
This is followed by pushing up the uterine manipulator to visualise the vagina. The vagina is 
cut with the monopolar hook, using the manipulator as a guide to free the uterus completely.  
7. Retrieval of the uterus or morcellation  
The uterus is pushed through the vagina and may be left in the vagina until the cuff is closed 
or a large gauze swab in a glove is placed into the vagina to prevent gas loss. In cases of large 
uteri a Rotocut G1 morcellator (Fa. Karl Storz, Tuttlingen, Germany) is used.  
8. Vaginal closure 
The rest of the vaginal cuff is closed with a polydioxanone (PDS) suture on a curved needle 
using an extracorporeal Roeder knot secured by 2-3 intracorporeal safety knots. The surgeon 
starts with the corner stitch performing the Te Linde suture adapted by van Herendael.  
The pelvic sidewall is inspected for bleeding. Successive irrigation and suction are performed 
to ensure the removal of small morcellated parts. All instruments are then removed, the fascia 
and the port entries are sutured under vision. 
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Figure 1. Separation of the round ligament with NightKNIFE ® (BOWA, Gomaringen, 
Germany)  
 





Figure 3. Opening of the vagina following the landmarks between the vessel’s root  
 
Figure 4. First corner stitch on the right 
 




2.2.4. Laparoscopic Supracervical Hysterectomy (LASH) 
1. Patient setting 
After the induction of anesthesia, the patient’s legs are placed in padded Allen stirrups. The 
buttocks must protrude a few centimeters from the edge of the table to allow uterine 
manipulation. It is always recommended to administer a single dose antibiotic at the 
beginning of the operation. The five safety measures are performed before insertion of the 
Veress needle; aorta palpation test, needle Flow test, snap test, hiss phenomenon and 
aspiration test. The primary trocar (umbilicus for camera entry) and the secondary trocar 
(right and left iliac fossa) are placed under vision to allow exploration of abdominal and 
pelvic anatomy. In an enlarged uterus the usage of two 10mm ports at a slightly higher 
position is to be considered. 
2. Separation of adnexa  
Without BSO (bilateral salphinogo-ophrectomy): The uterus is pulled to the respective side by 
grasping forceps, followed by coagulation and cutting of the round ligament and ovarian 
ligament. With BSO, coagulate and cut the infundibulopelvic ligament, the tubes and the 
proper ovarian ligament (ligamentum ovarii proprium) to remove the ovaries and the tubes. 
The adnexa can be left adjacent to the uterus. It is necessary to visualize the ureter during and 
after removal.  
3. Dissection of broad ligament and uterine artery  
The broad ligament is dissected by alternative coagulation and sharp dissection. After 
identification and skeletonization of the uterine vessels, bleeding is controlled by bipolar 
coagulation and the vessels are dissected using Metzenbaum scissors. 
4. Dissection of the bladder peritoneum 
Grasping forceps are used to pull the uterus to the contralateral side. Bipolar coagulation zone 
is placed on the bladder peritoneum. The vesicouterine fold of the peritoneum is coagulated 
and then opened with scissors. It is not necessary to push away the bladder.  
5. Excision of the uterus 
The corpus of the uterus is severed from the cervix with a monopolar hook or loop, or 
harmonic hook, slowly layer by layer. Hemostasis is achieved by coagulating the cervix 
stump; the endocervical canal is also coagulated to achieve efficient hemostasis. 
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6. Peritonisation of the cervix 
 Peritonisation is performed by taking the peritoneum anteriorly and continuing in a purse 
string manner, including the sacro- uterine ligaments posteriorly. In this manner the cervix is 
covered by the peritoneum.  
7. Morcellation of the uterus 
The incision on the left side is widened for the morcellator, which is introduced under direct 
vision, and the corpus is removed by morcellation. The remaining small pieces of the uterus 
or the myoma are retrieved using the grasping forceps. The peritoneum is then closed using 
bipolar forceps. Gas is released. Closure of the fascia is required if the incision is larger than 
10mm. Successive irrigation and suction are performed to ensure removal of smaller 
morcellated parts. The instruments are afterwards removed and the port incisions closed. 
2.2.5 Laparoscopic Assisted Vaginal Hysterectomy (LAVH) 
1. Patient setting 
After the induction of anesthesia, the patient’s legs are placed in padded Allen stirrups. The 
abdomen, perineum and vagina are prepared with a suitable bactericidal solution and a Foley 
catheter is inserted.  
The Veress needle, primary trocar (umbilicus for camera entry) and the secondary trocar 
(right and left iliac fossa) are inserted to allow exploration of abdominal and pelvic anatomy. 
In an enlarged uterus the usage of two 10mm ports at a slightly higher position is to be 
considered. It is always recommended to administer a single dose of prophylactic antibiotics. 
2. Separation of adnexa  
Steps for surgery, without BSO (bilateral salphinogo-ophrectomy): The uterus is pulled to the 
respective side by grasping forceps followed by coagulation and cutting of the round ligament 
and ovarian ligament. With BSO, coagulate and cut the infundibulopelvic ligament to remove 
the ovaries.  
3. Dissection of broad ligament 
The round ligaments must be coagulated with bipolar forceps and cut. If preservation of the 
adnexa is preferred, a dissection of the utero-ovarian ligament close to the overy must be 
preserved. The leaves of the broad ligament are opened and the anterior broad ligaments are 
opened downward and towards the bladder.  
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4. Dissection of the bladder peritoneum 
 The uterovesical junction is identified, grasped and elevated with grasping forceps and then 
cut with scissors. The bladder pillars are first coagulated and cut, completely freeing the 
bladder from the uterus by pushing downwards.  
5. Transformation to the vaginal route 
The cervix is grasped with two single-toothed tenacula. A circular incision around the cervix 
about 5 mm above the external os is performed followed by separation of the vaginal wall 
from the cervix. The border between the anterior wall of the uterus and the bladder must be 
identified. The bladder is pushed up, always as close as possible to the uterus. It separates and 
moves up until the anterior peritoneum is opened.  
The posterior peritoneum is opened after separating the vaginal epithelium posteriorly. The 
paracervical tissues and the uterosacral ligaments are then clamped together, cut, ligated and 
the suture material is left in full length.  
6. Dissection of uterine artery 
This is repeated on the other side. The Cardinal ligaments and uterine arteries on either side 
are clamped, cut and ligated separately. The anterior peritoneum is opened, followed by the 
delivery of the uterus. After fixing the uterosacral ligaments and the cardinal ligaments to the 
vault, the vault is closed.  
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2. 3. Methods 
2.3.1. Data collection 
The data were retrospectively collected from patient records and analyzed. The operation 
information lists were collected from the operation recording archive data backup for the 
period January 2002- October 2010. The patient’s data were collected from files and 
organised in a spreadsheet according to the evaluated data including patient’s age, BMI, 
parities, former operations, indications of operation, duration of hospital stay, operating time, 
weight of uterus, histopathological report of removed specimen, hemoglobin decrease and 
intra- and postoperative complications. The operating time was calculated from the first 
incision till the final stitches. The body mass index (BMI) was calculated using the formula 
weight in kilograms divided by the patient’s height in square meters. The Hemoglobin level 
was measured one day preoperatively and remeasured one day post operatively and the 
difference was recorded. The uterus weight was recorded from the pathology reports. Thirty 
patients were completely excluded from the comparsion criteria due to inproper or incomplete 
recording of the patient data. The perioperative score was recorded by 785 patients. 
2.3.2. Criteria of comparison 
All patients who underwent a hysterectomy in the period from January 2002 to October 2010 
for benign uterine disease were included in our comparison criteria. In order to have clear 
comparison parameters, we deceided to define a preoperative score and to classify the 
intraoperative and postoperative complications into major and minor. 
Preoperative score  
All patients who had undergone a previous laparoscopy were given 1 point, for a previous 
laparotomy 2 points, for (1x) caeserian section 3 points, for (2x) caeserian sections 4 points, 
for (3x) caeserian sections 5 points and for no previous operation 0 points. 
Intraoperative complications 
Injury to blood vessels requiring a blood transfusion, the intestines, rectum and urinary tract 
injury, including ureter and urinary bladder, are classified as intraoperative complications. 
Postoperative complications 
Postoperative complications were categorized into major and minor. The major included 
postoperative bleeding and revision operation and the minor postoperative complications 
included haematoma, vaginal bleeding, wound infection, burning sensation, urinary tract 
infection and fever. 
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2.3.3. Statistic analysis 
The data were registered in the computer by creating a spreadsheet. The IBM SPSS statistics 
program were used to log and analyize the data. We received statistical advice from the 
Medistat GmbH office. The statistical analyses were used to examine differences within the 
five groups concerning the analyzed parameters. The tests used for statistical calculations 
were as follows: 1) Chi-Square Test for use in the analysis of the difference between two 
proportions 2) T-test to test the for the significance of the difference between two proportions 
or percentages and 3) U-Test from Mann Withney and Wilcoxon to compare one quantitative 
value between two groups of patients. Demographic and surgical data were analyzed by 
analysis of variance (ANOVA), Kruskal-Walis-, Chi-square- or Fischer’s test. For the 
parameters age, BMI, hospital stay, operation duration, uterus weight and hemoglobin 
decrease an average value was obtained and a calculation of standard deviation was done. A p 
value less than 0.05 was considered to be statistically significant. We also used the Lilliefors 
significance correlation, where a significant correlation R value of more than 0.2 was 




3.1 Indications for the Operations 
Uterine myoma (65.19%), adenomyosis (11.21%), dysfunctional uterine bleeding (12.99%), 
endometriosis (5.03%), hyperplasia of the endometrium of the cervix (1.99%) and total 
uterine prolapse (14.79%) were the six most common reasons for the hysterectomy procedure 
in the period from 2002 – 2010 (Table 1).   
A total of 296 AH were performed, 9 (3.2%) operations were excluded from our study due to 
malignant histopathological findings. Overall 405 VH were performed, 12 (2.9%) operations 
were excluded as a result of malignant findings (vulvar and ovarian carcinoma) and 10 due to 
incomplete records. A total of 190 LASH were performed, 15 operations were excluded due 
to incomplete records and 7 (3.6%) patients due to malignant histopathological criteria. 
Seventy-six TLH were performed, 3 (3.9%) were excluded as a result of malignant 
histopathological findings and 5 due to incomplete records.  





3.1.1. Indications for VH  
 The main indications for vaginal hysterectomy were uterine myomas 158 (41.3%), 
adenomyosis 41 (10.7%), dysfunctional uterine bleeding 40 (10.6%), diffuse hyperplasia of 
the uterus and cervix 11 (2.9%), total prolapse 131 (33.9%) and endometriosis 6 (1.6%). 
Other indications (completed family planning) represented 20 cases (5.2%) (Table 1, Figure 
1). 
Figure 1. Operation indication for VH 
 
3.1.2. Indications for AH  
 The main indications for abdominal hysterectomy were uterine myomas 238 (82.9%), 
adenomyosis 22 (7.7%), dysfunctional uterine bleeding 37(12.9%), diffuse hyperplasia of the 
uterus and cervix 6 (2.0%), total prolapse 3 (1.0%) and endometriosis 12 (4.2%). Other 
indications (completed family planning) represented 7 cases (2.4%) (Table 1, Figure 2). 




3.1.3. Indications for TLH  
 The main indications for TLH were uterine myomas 50 (73.5%), adenomyosis 12 (17.6%), 
dysfunctional uterine bleeding 3 (25.0%), diffuse hyperplasia of the endometrium 1 (1.5%), 
and endometriosis 7 (10.3%). Other indications, such as completed family planning 
represented 4 cases (5.9%) (Table 1, Figure 3). 




3.1.4 Indications for LASH  
 The main indications for LASH were uterine myomas 145 (85.79%), adenomyosis 25 
(14.79%), dysfunctional uterine bleeding 39 (23.07%), total prolapse 4 (2.50%) and 
endometriosis 17 (10.05%) (Table 1, Figure 4). 
Figure 4. Operation indication for LASH 
 
3.1.5. Indications for LAVH  
 The main indications for LAVH were uterine myoma 31 (66.0%), adenomyosis 7 (14.9%), 
dysfunctional uterine bleeding 5 (10.6%), diffuse hyperplasia of the uterus and cervix 1 
(2.1%), total prolapse 3 (6.4%) and endometriosis 6 (12.8%). Other indications, such as 
completed family planning, represented 2 cases (4.3%) (Table 1, Figure 5). 






3.2. Patient age at the hysterectomy operation 
The average age of the patients at the time of the hysterectomy was 47.95 years (Figure 6). 
The average age for the AH was 44.84 years (40.00- 48.00), for the VH 52.97 years (43.00- 
64.00), for the LASH 44.38 years (41.00- 47.00), for the LAVH 44.53 years (41.00- 47.00), 
and for the TLH 44.13 (40.25- 47.75) (Figures 6, 7). 
Figure 6. Patient age at the time of hysterectomy operation 
 




3.3. BMI at the hysterectomy operation 
 The average BMI of the patients at the time for the hysterectomy was 25.85 (22.12- 28.15) 
(Figure 8). The average BMI for AH was 26.49, for VH 26.19, for LASH 24.27, for LAVH 
25.73 and for TLH 25.35. Furthermore, no significant correlation was found between BMI, 
uterus weight and operation duration (Figures 9, 10). 
Figure 8. Distribtion of BMI at hysterectomy  
 
Figure 9. Correlation between BMI and operation duration 
 






3.4. Parity at the hysterectomy operation 
 From 203 abdominal hysterectomies, 86 (42.6%) patients were nullipara, 95 (46.5%) uni-
bipara and 22 (10.9%) more than bipara and From 291 vaginal hysterectomies 16 (5.5%) 
patients were nullipara, 172 (59.1%) uni-bipara and 103 (35.4%) more than bipara. From 163 
LASH operations, 68 patients (41.7%) were nullipara, 76 (46.6%) uni-bipara and 19 (11.7%) 
more than bipara. From 43 LAVH operations, 7 (16.3%) patients were nullipara, 19 (44.7%) 
uni-bipara and 17 more than bipara. From 66 TLH operations, 17 (25.8%) were nullipara, 38 
(57.6%) uni-bipara and 11 (16.7%) more than bipara (Figure 11).  
The operation duration increased with a higher parity for all operation routes (Figure 12). 
Significant differences by the multipara by the VH in comparison to all others routes were 
found.  
Figure 11. Parity distribtion by the different operation routes 
 




3.5. Preoperative score at the hysterectomy operation 
The average preoperative score for the AH was 1.09, for the VH 0.75, for the LASH 1.04, for 
the LAVH 1.0 and the highest preoperative score was recorded by the TLH 1.38 (Figure 12). 
The prevalent scores in the VH were 0 and 1, the LASH and TLH showed a prevalence over 
VH in the preoperative scores 3 and 4 and AH showed a prevalence over the other methods in 
the preoperative score 3 - 8 (Table 2). 
Figure 12. Distribution of the preoperative score according to the hysterectomy  
 




3.6. Length of hospital Stay for the Hysterectomy  
The average hospital stay for the AH was 7.92 days, for the VH 6.74 days, for the LASH 3.88 
days, for the LAVH 5.85 days and for the TLH 4.32 days (Figure 13).  
The hospital stay was statistically tested against the BMI. However, the two tested parameters 
showed no significant correlation (Figure 14). 
Figure 13. Length of Hospital stays for the different hysterectomy route 
 




3.7. Operation duration for the Hysterectomy operation 
The average operation duration for the AH was 107.71 minutes, for LASH 106.59, for LAVH 
137.00 and for TLH 130.24 minutes. The shortest operation duration was recorded for VH 
76.03 minutes (Figure 15). 
The operating time of the TLH was shortened by 50 minutes in the period from 2007-2010, 
161.67 minutes in 2007 and 108.93 minutes in 2010. 




3.8. Uterus weight for the hysterectomy operation 
The average uterus weight after the hysterectomy was 263.89 grams (Figure 16). The average 
uterus weight for AH was 518.58 grams, for LASH 244.92 grams, for LAVH 159.24 grams 
and for TLH 205.11 grams. The lightest average uterine weight was for VH 127.77 grams 
(Figure 17).  
Figure 16. Uterus weight distribution 
 




3.9. Hemoglobin decrease for the hysterectomy operation 
The average hemoglobin decrease for AH was 1.63 g/dl, for the VH 1.29 g/dl, for LASH 0.70 
g/dl, for LAVH 1.83 g/dl and for the TLH 0.82 g/dl (Figure 18).  





From a total of 953 hysterectomies, 52 (5.5%) complications were recorded. Complications 
occurred in 24 (6.3%) cases of VH and in 19 (6.6%) cases of AH. Complications were 
recorded in 4 cases (2.4%) of the LASH, 3 (6.4%) cases of the LAVH and 2 (2.9%) cases of 
the TLH (Figure 19).  




3.10.1. Minor Complications 
Minor complications were recorded in 56 (5.87%) of 953 hysterectomies. In 23 (6.0%) cases 
of the VH and in 24 (8.4%) of the AH complications occurred. Complications were recorded 
in 3 (1.8%) of the LASH, 3 (6.4%) of LAVH and in 3 (4.4%) of the TLH (Figure 20). 
Haematoma were recorded in 15 of the AH, wound infection and urinary tract infection 
complications occurred in 5 cases of the VH (Table 3). 
Figure 20. Minor complication by the hysterectomy operation 
 




3.10.2. Major Complications 
From a total of 953 hysterectomies, 18 (1.78%) Major complications were recorded. It 
occurred in 7 (1.8%) at the VH and 4 (1.4%) at the AH. Complications were recorded in 3 
(1.2%) of the LASH, in 3 cases of LAVH (6.4%) and in only 1 (1.5%) case of the TLH 
(Figure 21). Major postoperative complications, such as bleeding and a revision operation 
were recorded in 3 cases by the LASH (Table 4).  
Figure 21. Distribution of major complications by hysterectomy operation 
 
Table 4. Major postoperative complications 
 
3.10.3. Intraoperative Complications 
Intraoperative complications were recorded in 28 (2.93%) of 953 hysterectomies. The 
distribution of intraoperative complications was as follows: 10 (2.6%) of the VH, 13 (4.5%) 
of the AH, 3 (1.8%) of the LASH, 1 (2.1%) of the LAVH and 1 (1.5%) of the TLH (Figure 
22). Intraoperative complications, such as urinary tract lesion and intestinal lesion, occurred 




Figure 22. Distrubtion of intraoperative complications by hysterectomy 
 
Table 5. Intraoperative complications 
 
3.10.4. Complication association 
Intraoperative complications occurred more frequently with increasing the uterine weight. 
Hemoglobin decline increased in the presence of intraoperative complications (Figures 23, 
24). Hospital stay and operation duration were prolonged in the presence of intraoperative 
complications showing a direct correlation, while the increase of BMI and uterine weight 
showed no correlation with postoperative complications (Figure 25, 26).  




Figure 24. Intraoperative complication correlation with hemoglobin decline at hysterectomy 
 








3.11. Significant statistical analysis 
A p value less than 0.05 were considered to be statistically significant. We also used the 
Lilliefors significance correlation, where a significant correlation R-value of more than 0.2 
was considered to be statistically correlated. 
The statistical analysis of VH compared to all other operation routes showed a significant 
difference regarding the patient’s age on the day of the operation (P < 0.05), while no 
significant changes were found within the other methods. The statistical analysis was 
significant by BMI between the LASH and VH and AH (P < 0.05) and no further significant 
findings were observed by the other operation routes. The preoperative score showed a 
significant difference in comparing the VH to LASH and TLH (P < 0.05). The hospital stay 
was significant by LASH and TLH in comparison to all other routes (P < 0.05). The operative 
duration of VH was significant in comparison to all the other routes and the LASH was 
statistical significant in comparison to the TLH and LAVH (P < 0.05). The uterus weight 
showed a significant difference between the various operation routes. The hemoglobin decline 
was statistical significant by the LASH and TLH in comparison to all others routes (P < 0.05) 
(Table 6). 






3.12. Main outcome results 
Patients with uterine myomas, endometriosis, additional adnexal pathology and high BMI 
benefit from the laparascopic access route in comparsion to AH and VH. 
Patients with prolapse, a higher parity score and a low preoperative score benefit from VH 
compared to LH and AH. 
VH is a safe natural orfice route for patients with a large number of vaginal delieveries and a 
low uterine weight. The operation duration is significantly shorter and postoperative results 
are comparable to laparoscopic hysterectomies. 
LASH and TLH are minimally invasive methods showing the lowest intraoperative and 
postoperative complication rate especially for patients with a high preoperative score and a 
high uterine weight. Laparoscopic hysterectomies showed the lowest hemoglobin decline and 
the shortest hospital stay and therefore should be the method of choice if VH is not possible. 
Intraoperative complications correlated with the increase in uterine weight, while no 
important correlations between BMI, age and uterine weight were observed. 
LASH and TLH are associated with a generally lower rate of complications in comparsion to 
AH and VH. The increase of BMI and uterine weight showed no correlation with 
postoperative complications. 
The growing prevalance of obesity, late first delivery and the increase in the preoperative 




This retrospective study is designed to investigate the different routes and methods of 
hysterectomy and aims to outline the indications for the hysterectomy operations, the 
development of the procedures, compare the different complication rates and outcomes and 
their associations with the operation route. Different factors seem to influence the decision for 
the desired hysterectomy procedure. 
Benign indications of hysterectomy include symptomatic or growing uterus myomas, 
dysfunctional uterine bleeding, endometriosis, adenomyosis and prolapse of the uterus (Stang 
et al. 2012; Schindlbeck et al. 2008). Uterus myoma is the most common indication for a 
hysterectomy (Müller A. et al. 2004). Myomas cause three main symptoms: pain, bleeding 
symptoms and infertility (Müller A. et al. 2004; Müller A. et al. 2007). In our study the main 
indications for hysterectomy were uterine myoma (65.2 %), adenomyosis (11.2%), prolapse 
(14.8%), hyperplasia of uterus and cervix (2.0%), menstrual disorder (14.8%) and 
endometriosis (5.0%). According to the AQUA-institute in 2010 in Germany the indications 
for hysterectomy operation were the following myomas 60.5%, prolapse 26.7%, menstural 
disorders 25.8%, hyperplasia of the uterus and cervix 2.0% and endometriosis 12.9%.  
In our study the shortest hospital stay, the lowest hemoglobin decline and lowest complication 
rate were recorded by LASH and TLH. LASH and TLH had the advantage of a shorter 
hospital stay (4 days) in comparison to AH and VH (6 and 7 days, respectively). In 
comparsion to our study; Schindlbeck’s study agrees with our results that LH has a shorter 
hospital stay than VH and AH (Schindlbeck et al. 2008). The shorter hospital stay is one of 
the factors explaining the increase in the numbers of laparoscopic procedures compared to 
AH.  
The number of laparoscopic operations is increasing steadily in our department whereas the 
number of VH and AH is decreasing steadily (Figures 27, 28). The literature shows that the 
number of AH started to decrease by 6-7% (Brandner et al. 1995) after the development of the 
first laparoscopic hysterectomy by Harry Reich 1988, the CISH by Semm  and the LASH by 
Donnez in 1993. Johnson’s  study (Cochrane database syst Rev.) agrees with the benefits of 
LH over AH and VH over AH (Johnson et al. 2006).  
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In the last three years in our department the number of AH and VH significantly decreased 
due to the increase of LASH and TLH operations. In the year 2010 LASH (37.9%) and TLH 
(15.3%) represented 53.1% of the total hysterectomies, while the VH and AH represented 
25% and 21.7% respectively (Figure 28). The AQUA Institute showed that the percentage of 
AH in Germany was 19.3%, whereas the ASF in Switzerland reported a percentage of 26%. 
The distribution of hysterectomies in Switzerland in 2010 was 41% VH, 27% TLH, 26% AH, 
2% LAVH and 2% LASH. The early establisment of the TLH and LASH techniqiues in our 
department in 2003 and 2004 and the standardization of the techniques through continous 
training in the Kiel endoscopy school resulted in a decrease in the incidence of complications. 
This in turn led to an increase in the number of laparoscopic hysterectomies in our 
department.  
The operation duration was shortest by VH and longest by TLH. The mean operating time by 
VH (75 min) showed a 50-minute difference to TLH. LASH and AH operations showed a 
mean operating time of (100 min), which is still 20 minutes shorter than LAVH. Many factors 
could be responsible for the variation in the operation duration; e.g the VH has practised for 
many years, which makes surgeons more familiar with the technique. A relatively large uterus 
or the presence of adhesions could result in prolonging the operation time of the TLH and 
AH. The time required for morcellation is one of the reasons for the lengthier operating time 
of LASH and TLH (Condous et al. 2009). The change in the route of operation by LAVH 
(from the abdominal route to the vaginal route) could be the main reason for the extended 
operating time (Chen et al. 2008). In the coming years a shorter operating duration is to be 
expected for laparoscopic operations as the experience of surgeons with this technique 
increases (Tan et al. 2009).  
The statistical analysis did not show any correlation between the increase of uterus weight and 
a lengthier hospital stay or prolonged operating duration. The results of our study disagree 
with the Schindlbeck study (Schindlbeck et al. 2008).  
The lowest complication rate was recorded for LASH (2.4%), and the highest complication 
rate for AH (6.6%). The complication rate for VH was 6.3%, which is higher than for TLH 
(2.9%) and slightly less than for LAVH (6.4%). The two well established laparoscopic 
techniques for hysterectomy (LASH and TLH) showed a lower complication rate than VH 
and AH due to the development of laparoscopic instruments, techniques and continous 
surgical training by training modules. These could be the decisive factors for achieving a safe 
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surgery with fewer complications in the near future. The availability of different sealing 
vessel coagulation systems and manipulators has resulted in easing the performance of LASH 
and TLH techniques (Mueller et al. 2012; Ou et al. 2004). Moreover, increased surgeon 
experience with the laparoscopic technique has resulted in a low complication rate.  
The FINHYST study showed a complication rate for AH of 19%, VH of 12% and for LH of 
15% (Brummer et al. 2011). An audit on hysterectomies in Hong Kong hospitals in 2002 also 
showed similar results where the complication rate was lower for VH compared to AH 
compared to LH (Leung et al. 2007); several authors have also reported the low complication 
rate by the LASH (Bojahr et al. 2006; Brill 2006; Lethaby et al. 2012; Lyons et al. 2004). A 
wide range of variation was found in the literature, Donnez, reported that LH did not show a 
significantly higher rate of complications in comparison to AH and VH (Donnez, O. et al. 
2009). 
The intra-operative complication rate for hysterectomies in 2010 in our department was 2.9%. 
The highest intra-operative complication rate occurred at abdominal hysterectomy (4.5%) and 
the lowest recorded at TLH (1.5%). In a retrospective single-center study in the period 2002–
2008 at the Department of Obstetrics and Gynecology, Erlangen University Hospital and the 
eVALuate study showed a variation of 1-2% for the intraopreative complication rate (Muller 
et al. 2010; Canis et al. 2004). In contrast the VALUE study reported a higher intraoperative 
complication for AH than for VH (McPherson et al. 2004).  
In our study the most commonly occurring intraoperative complications were urinary bladder 
lesions (7 cases). They occurred in 3 of VH (42.9%) and in 2 of AH (28.6%) and LASH 
(Table 5). In Finland the complication rate of urinary bladder lesion was 0.8% (Brummer et 
al. 2011). The literature study showed that urinary track lesions occur more frequently at LH 
(Nieboer et al. 2009; Muller et al. 2010; Schindlbeck et al. 2008).  
Injury to the intestine occurred twice at AH and once at LASH in our study. In comparison of 
the literature the complication rate for injury to the intestine was 0.24 % in Germany (Table 
7) and 0.2% in Finland (Brummer et al. 2011). Injury to blood vessels and intra-operative 
bleeding occurred 9 times at AH, 7 times at VH, once at the LAVH and once at TLH 
representing an overall complication rate of 1.89%. In the FINHYST study intraoperative 
bleeding and injury to blood vessels represented 3.0% (Brummer et al. 2011).  
In our study, an association was found between intraoperative complications and the increase 
of uterine weight (Figure 23). This finding is in agreement with the literature (Hillis et al. 
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1996). The BMI and age of the patient didnot show a direct correlation to intraoperative 
complications. The percentage of intraoperative complications for nullipartus is 26.1%, for 
partus 1-2 43.5% and for partus >2 30.4%.  
Postoperative complications are classified into two groups, major and minor complications. 
The major postoperative complication rate was 1.8% and the minor postoperative 
complication rate was 5.9%. According to the AQUA Institute the postoperative complication 
rate by the hysterectomies in Germany in 2010 was 4.5%. In our study the highest incidence 
of major complications was recorded for LAVH (6.4%) and the lowest incidence for LASH 
(1.2%). The lowest minor postoperative complication rate was recorded for LASH (1.8%) and 
highest for AH (8.4%). Revision-operation was done 6 times by VH, representing the highest 
incidence in the major complications, 3 times by LAVH, 2 times by LASH and once by TLH. 
Haematoma formation was the most commonly occurring minor postoperative complication 
in our study representing 3.36%. In comparsion in the literature, a minor postoperative 
complication rate of 0.94% was recorded in Germany 2010 (Table 7). In our study fever 
accounted for 0.84% compared to 0.28% in the AQUA Institute study. Table 7 shows a 
detailed comparison between the incidence rates of complications by hysterectomies. The 
mortality rate in the AQUA Institute study was recorded as 35 of 112.618 hysterectomies; in 
our study no mortality case was recorded. 
LASH and TLH showed the lowest hemoglobin decrease (0.70g/dl, 0.82g/dl), while AH 
showed the highest hemoglobin decrease 1.63g/dl. The hemoglobin loss at VH was 1.29g/dl, 
which is higher than for LASH or TLH. The development of coagulation systems and the 
greater magnification at laparoscopy gives an advantage over other methods. By comparing 
the literature the Hwang study also showed more blood loss by VH than by AH (Hwang et al. 
2002). Candiani showed the lowest hemoglobin loss for LH than by VH (Candiani et al. 
2009). Many discrepancies between studies concerning hemoglobin loss are to be noticed. 
The question nowadays is whether the LH is taking over or replacing VH. In our study LH 
(TLH and LASH) has advantages by the hospital stay, complication rates and haemoglobin 
decline over VH and AH (Table 8). The literature shows that VH has various advantage over 
LH and AH (Johnson et al. 2006; Muller et al. 2010). We are also aware that different 
parameters (post operative pain, speedy convalescence and economic factors) were not 
included in our study. From the literature point of view the natural orfice hysterectomy (VH) 
is still the method of choice (Johnson et al. 2006; Canis et al. 2004; Ark et al. 2009) especially 
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in combination with small uterus or correction of prolapse. The indication for LAVH is 
restricted, whenever TLH or LASH not technically possible or if vaginal corrective surgery is 
planned at the same time. 
In a comparison of LASH and TLH, there was only a very narrow range of difference 
regarding operation duration and hospital stay. Moreover, the well known disadvantages of 
the subtotal hysterectomy to the total hysterectomy remain (Bojahr et al. 2006; Thakar et al. 
2002; Washington 2005; Grosse-Drieling et al. 2012); risks of cervical cancer, regular 
examination, cyclic scanty bleeding (Theben et al. 2012). A more detailed evaluation of life 
quality and prolapse after LASH is required. In recent literature, the TLH in the hand of 
experienced surgeons showed no increase in the complication rate compared to LASH 
(Donnez, O. et al. 2009; Wattiez et al. 2002; Grosse-Drieling et al. 2012).  
The ACOG, the Canadian and the European councils, despite a minimal significant 
difference, still consider VH to be the method of choice, followed by LH. AH should be 
performed when LH is not possible (Johnson et al. 2006; 2008; Kives et al. 2010).  
To sum up, the decision for the route of hysterectomy is dependent on the surgeon’s 
experience and the indication for the operation. Shared decision-making and consent between 
the surgeon and patient is highly recommended. This decision should be individualized for 




Background and aims 
The aim of this study is to compare the data of patients and the operating parameters of the 
five different surgical techniques of hysterectomy (VH = vaginal hysterectomy, AH = 
abdominal hysterectomy, TLH = total laparoscopic hysterectomy, LASH = laparoscopic 
supracervical hysterectomy, LAVH = laparoscopic-assisted vaginal hysterectomy).  
Methods 
Patients 
 A total of 954 patients underwent a hysterectomy in the period from January 2002 to October 
2010 for benign uterine disease. 
Material 
The data were retrospectively collected from patients’ records and analyzed. The evaluated 
data included patient’s age, BMI, parities, former operations, indications of operation, 
duration of hospital stay, operating time, weight of uterus, histopathological report of 
removed specimen, hemoglobin fall and intra- and postoperative complications. 
Statistical analysis 
A statistical analysis was used to examine differences within the five groups concerning the 
analyzed parameters. Demographic and surgical data were analyzed by ANOVA, Kruskal-
 alis-,  hi-square- or Fisher  s test.   
Results 
The average age recorded for all hysterectomies was 47.95 years and the average BMI was 
25.85. By comparing all methods, the most common indications for hysterectomy were 
uterine myoma (65.2%), adenomyosis (11.2%), prolapse (14.8%), hyperplasia of uterus and 
cervix (2.0%), menstrual disorder (14.8%) and endometriosis (5,0%). 
The hospital stay was the longest for AH (7.92 days) and the shortest for LASH (3.88). For 
VH the average hospital stay was 6.74 days, for LAVH 5.85 and for TLH 4.32 days. The 
shortest operating time was for VH (76.03 minutes) and the longest for LAVH (137 minutes). 
For AH the average operating time was AH 107.71 minutes, for LASH 106.59 and for TLH 
130.24 minutes.  
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The average uterine weight was heaviest for AH 518.58 (170.00- 721.50) grams and lightest 
for VH 127.77 (59.50-168.50). The average uterine weight for LASH was 244.92 (118.00- 
310.00), for LAVH 159.24 (100.50- 181.00) and for TLH 205.11 (114.00- 224.00). The 
lowest average hemoglobin decrease for LASH was 0.70 g/dl, for AH 1.63 g/dl, where as for 
VH it was 1.29 g/dl, for LAVH 1.83 g/dl and for TLH 0.82 g/dl. 
The lowest complication rate was recorded for LASH (2.4%) and the highest for AH (6.6%). 
The complication rate for VH was 6.3%, which was higher than TLH (2.9%) and slightly 
lower than LAVH (6.4%). The two well established laparoscopic techniques for hysterectomy 
(LASH and TLH) showed a lower complication rate than VH and AH. 
 The intraoperative complication rate for hysterectomies operations was 2.9%. The highest 
intraoperative complication rate occurred at abdominal hysterectomy (4.5%) and the lowest at 
TLH (1.5%).  
Postoperative complications are classified into two major groups; major and minor 
complications. The major postoperative complication rate was 1.8% and the minor 
postoperative complication rate was 5.9 %. 
The highest incidence of major complications was recorded by LAVH (6.4%) and the lowest 
by LASH (1.2%). The lowest minor postoperative complication rate was recorded by LASH 
(1.8%) and the highest by AH (8.4%).  
Conclusions 
Patients with uterine myomas, endometriosis, additional adnexal pathology and high BMI 
benefit from the laparascopic access route in comparsion to AH and VH. 
Patients with prolapse, a higher parity score and a low preoperative score benefit from VH 
compared to LH and AH. 
VH is a safe natural orfice route for patients with a large number of vaginal delieveries and a 
low uterine weight. The operation duration is significantly shorter and postoperative results 
are comparable to laparoscopic hysterectomies. 
LASH and TLH are minimally invasive methods showing the lowest intraoperative and 
postoperative complication rate especially for patients with a high preoperative score and a 
high uterine weight. Laparoscopic hysterectomies showed the lowest hemoglobin decline and 
the shortest hospital stay and therefore should be the method of choice if VH is not possible. 
  
48 
Intraoperative complications correlated with the increase in uterine weight, while no 
important correlations between BMI, age and uterine weight were observed. The hospital stay 
was statistically tested against the BMI. However, showed no significant correlation 
LASH and TLH are associated with a generally lower rate of complications in comparsion to 
AH and VH. 
The growing prevalance of obesity, late first delivery and the increase in the preoperative 




Figure 27. Development of hysterectomy operation 
 




Table 7. Incidence of intra- and postoperative complications (AQUA 2010. n = 112.618 
indepedent from the hysterectomy route. UKSH 2010. n= 953 indepedent from the 
hysterectomy route) 
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